High Throughput Genetic Analysis of Congenital Myasthenic Syndromes Using Resequencing Microarrays
Author Information
Author(s): Denning Lisa, Anderson Jennifer A., Davis Ryan, Gregg Jeffrey P., Kuzdenyi Jennifer, Maselli Ricardo A.
Primary Institution: University of California at Davis
Hypothesis
The study aims to evaluate the performance of a custom resequencing microarray for mutational analysis of Congenital Myasthenic Syndromes (CMSs).
Conclusion
The microarray prototype exhibited strong performance and proved highly efficient for screening genes associated with CMSs.
Supporting Evidence
- The microarray achieved an overall call rate of 93.61%.
- The microarray detected 22 out of 23 known missense mutations.
- The sensitivity of the microarray for missense mutations was 95.65%.
- The specificity of the microarray was 100%.
- The overall reproducibility of the microarray was 99.996%.
Takeaway
Researchers created a special test to find genetic problems in people with a muscle disease, and it worked really well for most types of problems.
Methodology
The study used custom resequencing microarrays to analyze DNA from individuals with known CMS mutations and healthy controls.
Limitations
The microarray could not efficiently assay insertion and deletion mutations.
Participant Demographics
The study included 21 patients with known CMS mutations and 5 healthy controls.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website